Learn more about whether Inari Medical, Inc. or DENTSPLY SIRONA Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Bausch + Lomb Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

The company's innovative medical devices, designed to treat venous ... $601.5 million and $604.5 million. Furthermore, Inari's ClotTriever Thrombectomy System for deep vein thrombosis has received ...

Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

The company’s portfolio of mechanical thrombectomy devices is set to ‘complement ... subject to the satisfaction of the closing conditions. Inari Medical CEO Drew Hykes said: “Inari ...

Stryker's definitive agreement to purchase Inari Medical aims to enhance its product offerings by adding Inari's mechanical thrombectomy devices to its neurovascular portfolio. The integration is ...

Stryker's definitive agreement to purchase Inari Medical aims to enhance its product offerings by adding Inari's mechanical thrombectomy devices to its neurovascular portfolio. The integration is ...

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ...